nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpropamide—ABCB1—Mitomycin—urinary bladder cancer	0.198	0.305	CbGbCtD
Chlorpropamide—PTGS1—Etoposide—urinary bladder cancer	0.104	0.16	CbGbCtD
Chlorpropamide—SLC22A6—Methotrexate—urinary bladder cancer	0.0603	0.093	CbGbCtD
Chlorpropamide—ABCB1—Gemcitabine—urinary bladder cancer	0.057	0.0878	CbGbCtD
Chlorpropamide—CYP2C9—Fluorouracil—urinary bladder cancer	0.0502	0.0774	CbGbCtD
Chlorpropamide—CYP2C9—Cisplatin—urinary bladder cancer	0.0427	0.0657	CbGbCtD
Chlorpropamide—ABCB1—Cisplatin—urinary bladder cancer	0.0414	0.0638	CbGbCtD
Chlorpropamide—ABCB1—Etoposide—urinary bladder cancer	0.0407	0.0627	CbGbCtD
Chlorpropamide—ABCC8—penis—urinary bladder cancer	0.0294	0.212	CbGeAlD
Chlorpropamide—ABCB1—Doxorubicin—urinary bladder cancer	0.0278	0.0427	CbGbCtD
Chlorpropamide—ABCB1—Methotrexate—urinary bladder cancer	0.0269	0.0414	CbGbCtD
Chlorpropamide—CYP2C19—urine—urinary bladder cancer	0.0113	0.0814	CbGeAlD
Chlorpropamide—CYP2C9—urine—urinary bladder cancer	0.00876	0.0631	CbGeAlD
Chlorpropamide—ABCC8—prostate gland—urinary bladder cancer	0.00703	0.0507	CbGeAlD
Chlorpropamide—ABCC8—seminal vesicle—urinary bladder cancer	0.00595	0.0428	CbGeAlD
Chlorpropamide—ABCC8—smooth muscle tissue—urinary bladder cancer	0.00498	0.0359	CbGeAlD
Chlorpropamide—SLC15A1—epithelium—urinary bladder cancer	0.00494	0.0356	CbGeAlD
Chlorpropamide—ABCC8—renal system—urinary bladder cancer	0.00479	0.0345	CbGeAlD
Chlorpropamide—SLC15A1—renal system—urinary bladder cancer	0.00458	0.033	CbGeAlD
Chlorpropamide—SLC15A2—prostate gland—urinary bladder cancer	0.0042	0.0303	CbGeAlD
Chlorpropamide—KCNJ11—female reproductive system—urinary bladder cancer	0.00417	0.03	CbGeAlD
Chlorpropamide—Eruption—Gemcitabine—urinary bladder cancer	0.0038	0.0254	CcSEcCtD
Chlorpropamide—Inappropriate antidiuretic hormone secretion—Cisplatin—urinary bladder cancer	0.00375	0.025	CcSEcCtD
Chlorpropamide—SLC15A2—seminal vesicle—urinary bladder cancer	0.00356	0.0256	CbGeAlD
Chlorpropamide—SLC15A1—vagina—urinary bladder cancer	0.00332	0.0239	CbGeAlD
Chlorpropamide—Pancytopenia—Mitomycin—urinary bladder cancer	0.0033	0.022	CcSEcCtD
Chlorpropamide—PTGS1—prostate gland—urinary bladder cancer	0.00287	0.0207	CbGeAlD
Chlorpropamide—SLC15A2—renal system—urinary bladder cancer	0.00286	0.0206	CbGeAlD
Chlorpropamide—SLC15A2—urethra—urinary bladder cancer	0.00281	0.0203	CbGeAlD
Chlorpropamide—Fluid retention—Thiotepa—urinary bladder cancer	0.00264	0.0176	CcSEcCtD
Chlorpropamide—Drug interaction—Gemcitabine—urinary bladder cancer	0.00252	0.0168	CcSEcCtD
Chlorpropamide—KCNJ11—lymph node—urinary bladder cancer	0.00244	0.0176	CbGeAlD
Chlorpropamide—PTGS1—seminal vesicle—urinary bladder cancer	0.00243	0.0175	CbGeAlD
Chlorpropamide—Glipizide—PPARG—urinary bladder cancer	0.00243	1	CrCbGaD
Chlorpropamide—SLC15A2—female reproductive system—urinary bladder cancer	0.00229	0.0165	CbGeAlD
Chlorpropamide—Fluid retention—Gemcitabine—urinary bladder cancer	0.00222	0.0148	CcSEcCtD
Chlorpropamide—Leukopenia—Mitomycin—urinary bladder cancer	0.00216	0.0144	CcSEcCtD
Chlorpropamide—PTGS1—epithelium—urinary bladder cancer	0.00211	0.0152	CbGeAlD
Chlorpropamide—SLC15A2—vagina—urinary bladder cancer	0.00207	0.0149	CbGeAlD
Chlorpropamide—Fluid retention—Cisplatin—urinary bladder cancer	0.00207	0.0138	CcSEcCtD
Chlorpropamide—PTGS1—smooth muscle tissue—urinary bladder cancer	0.00203	0.0146	CbGeAlD
Chlorpropamide—Pruritus—Valrubicin—urinary bladder cancer	0.00203	0.0135	CcSEcCtD
Chlorpropamide—CYP2C19—vagina—urinary bladder cancer	0.002	0.0144	CbGeAlD
Chlorpropamide—Diarrhoea—Valrubicin—urinary bladder cancer	0.00196	0.0131	CcSEcCtD
Chlorpropamide—PTGS1—renal system—urinary bladder cancer	0.00196	0.0141	CbGeAlD
Chlorpropamide—Eruption—Methotrexate—urinary bladder cancer	0.00195	0.013	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00193	0.0129	CcSEcCtD
Chlorpropamide—Dizziness—Valrubicin—urinary bladder cancer	0.00189	0.0126	CcSEcCtD
Chlorpropamide—Anorexia—Mitomycin—urinary bladder cancer	0.00188	0.0126	CcSEcCtD
Chlorpropamide—Vomiting—Valrubicin—urinary bladder cancer	0.00182	0.0122	CcSEcCtD
Chlorpropamide—Eruption—Epirubicin—urinary bladder cancer	0.00182	0.0121	CcSEcCtD
Chlorpropamide—Rash—Valrubicin—urinary bladder cancer	0.00181	0.0121	CcSEcCtD
Chlorpropamide—Headache—Valrubicin—urinary bladder cancer	0.00179	0.012	CcSEcCtD
Chlorpropamide—Haemolytic anaemia—Cisplatin—urinary bladder cancer	0.00175	0.0117	CcSEcCtD
Chlorpropamide—CYP2C9—female reproductive system—urinary bladder cancer	0.00172	0.0124	CbGeAlD
Chlorpropamide—Decreased appetite—Mitomycin—urinary bladder cancer	0.00172	0.0114	CcSEcCtD
Chlorpropamide—Nausea—Valrubicin—urinary bladder cancer	0.0017	0.0114	CcSEcCtD
Chlorpropamide—ABCB1—prostate gland—urinary bladder cancer	0.0017	0.0122	CbGeAlD
Chlorpropamide—Eruption—Doxorubicin—urinary bladder cancer	0.00168	0.0112	CcSEcCtD
Chlorpropamide—Pancytopenia—Thiotepa—urinary bladder cancer	0.00166	0.0111	CcSEcCtD
Chlorpropamide—Hyponatraemia—Cisplatin—urinary bladder cancer	0.00159	0.0106	CcSEcCtD
Chlorpropamide—PTGS1—female reproductive system—urinary bladder cancer	0.00157	0.0113	CbGeAlD
Chlorpropamide—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00145	0.00969	CcSEcCtD
Chlorpropamide—ABCB1—seminal vesicle—urinary bladder cancer	0.00144	0.0103	CbGeAlD
Chlorpropamide—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00143	0.00954	CcSEcCtD
Chlorpropamide—PTGS1—vagina—urinary bladder cancer	0.00142	0.0102	CbGeAlD
Chlorpropamide—Pancytopenia—Gemcitabine—urinary bladder cancer	0.00139	0.0093	CcSEcCtD
Chlorpropamide—Pancytopenia—Fluorouracil—urinary bladder cancer	0.00137	0.00915	CcSEcCtD
Chlorpropamide—Diarrhoea—Mitomycin—urinary bladder cancer	0.00135	0.00901	CcSEcCtD
Chlorpropamide—SLC15A2—lymph node—urinary bladder cancer	0.00134	0.00967	CbGeAlD
Chlorpropamide—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.00132	0.00879	CcSEcCtD
Chlorpropamide—Dizziness—Mitomycin—urinary bladder cancer	0.0013	0.00871	CcSEcCtD
Chlorpropamide—Pancytopenia—Cisplatin—urinary bladder cancer	0.0013	0.00867	CcSEcCtD
Chlorpropamide—Jaundice cholestatic—Epirubicin—urinary bladder cancer	0.00127	0.00851	CcSEcCtD
Chlorpropamide—Vomiting—Mitomycin—urinary bladder cancer	0.00125	0.00837	CcSEcCtD
Chlorpropamide—ABCB1—epithelium—urinary bladder cancer	0.00125	0.00898	CbGeAlD
Chlorpropamide—Rash—Mitomycin—urinary bladder cancer	0.00124	0.0083	CcSEcCtD
Chlorpropamide—Headache—Mitomycin—urinary bladder cancer	0.00124	0.00825	CcSEcCtD
Chlorpropamide—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00122	0.00815	CcSEcCtD
Chlorpropamide—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.0012	0.00801	CcSEcCtD
Chlorpropamide—Pancytopenia—Etoposide—urinary bladder cancer	0.00119	0.00794	CcSEcCtD
Chlorpropamide—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.00118	0.00787	CcSEcCtD
Chlorpropamide—Nausea—Mitomycin—urinary bladder cancer	0.00117	0.00782	CcSEcCtD
Chlorpropamide—ABCB1—renal system—urinary bladder cancer	0.00116	0.00833	CbGeAlD
Chlorpropamide—ABCB1—urethra—urinary bladder cancer	0.00114	0.00818	CbGeAlD
Chlorpropamide—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.00112	0.0075	CcSEcCtD
Chlorpropamide—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.00111	0.00741	CcSEcCtD
Chlorpropamide—Leukopenia—Thiotepa—urinary bladder cancer	0.00109	0.00726	CcSEcCtD
Chlorpropamide—Fluid retention—Epirubicin—urinary bladder cancer	0.00106	0.0071	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.00105	0.00702	CcSEcCtD
Chlorpropamide—Agranulocytosis—Etoposide—urinary bladder cancer	0.00104	0.00696	CcSEcCtD
Chlorpropamide—Fluid retention—Doxorubicin—urinary bladder cancer	0.000984	0.00656	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.000973	0.00649	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000972	0.00648	CcSEcCtD
Chlorpropamide—Erythema multiforme—Etoposide—urinary bladder cancer	0.000949	0.00633	CcSEcCtD
Chlorpropamide—Anorexia—Thiotepa—urinary bladder cancer	0.000946	0.00631	CcSEcCtD
Chlorpropamide—ABCB1—female reproductive system—urinary bladder cancer	0.000926	0.00667	CbGeAlD
Chlorpropamide—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.000921	0.00614	CcSEcCtD
Chlorpropamide—PTGS1—lymph node—urinary bladder cancer	0.000916	0.0066	CbGeAlD
Chlorpropamide—Leukopenia—Gemcitabine—urinary bladder cancer	0.000916	0.00611	CcSEcCtD
Chlorpropamide—Leukopenia—Fluorouracil—urinary bladder cancer	0.0009	0.00601	CcSEcCtD
Chlorpropamide—Dyspepsia—Thiotepa—urinary bladder cancer	0.000874	0.00583	CcSEcCtD
Chlorpropamide—Decreased appetite—Thiotepa—urinary bladder cancer	0.000863	0.00576	CcSEcCtD
Chlorpropamide—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.000862	0.00575	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000857	0.00572	CcSEcCtD
Chlorpropamide—Leukopenia—Cisplatin—urinary bladder cancer	0.000853	0.00569	CcSEcCtD
Chlorpropamide—ABCB1—vagina—urinary bladder cancer	0.000838	0.00603	CbGeAlD
Chlorpropamide—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.000833	0.00556	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000817	0.00545	CcSEcCtD
Chlorpropamide—Hyponatraemia—Epirubicin—urinary bladder cancer	0.000816	0.00545	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000804	0.00536	CcSEcCtD
Chlorpropamide—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000797	0.00532	CcSEcCtD
Chlorpropamide—Anorexia—Gemcitabine—urinary bladder cancer	0.000796	0.00531	CcSEcCtD
Chlorpropamide—Urticaria—Thiotepa—urinary bladder cancer	0.000788	0.00526	CcSEcCtD
Chlorpropamide—Anorexia—Fluorouracil—urinary bladder cancer	0.000782	0.00522	CcSEcCtD
Chlorpropamide—Leukopenia—Etoposide—urinary bladder cancer	0.000782	0.00522	CcSEcCtD
Chlorpropamide—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.000771	0.00514	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000762	0.00508	CcSEcCtD
Chlorpropamide—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.000755	0.00504	CcSEcCtD
Chlorpropamide—Eosinophilia—Methotrexate—urinary bladder cancer	0.000743	0.00496	CcSEcCtD
Chlorpropamide—Anorexia—Cisplatin—urinary bladder cancer	0.000742	0.00495	CcSEcCtD
Chlorpropamide—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000726	0.00484	CcSEcCtD
Chlorpropamide—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000723	0.00482	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000721	0.00481	CcSEcCtD
Chlorpropamide—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000714	0.00476	CcSEcCtD
Chlorpropamide—Pancytopenia—Methotrexate—urinary bladder cancer	0.000713	0.00476	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000709	0.00473	CcSEcCtD
Chlorpropamide—Pruritus—Thiotepa—urinary bladder cancer	0.000702	0.00468	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000698	0.00466	CcSEcCtD
Chlorpropamide—Eosinophilia—Epirubicin—urinary bladder cancer	0.000696	0.00464	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000685	0.00457	CcSEcCtD
Chlorpropamide—Anorexia—Etoposide—urinary bladder cancer	0.000679	0.00453	CcSEcCtD
Chlorpropamide—Diarrhoea—Thiotepa—urinary bladder cancer	0.000679	0.00453	CcSEcCtD
Chlorpropamide—Decreased appetite—Cisplatin—urinary bladder cancer	0.000676	0.00451	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000672	0.00448	CcSEcCtD
Chlorpropamide—Pancytopenia—Epirubicin—urinary bladder cancer	0.000667	0.00445	CcSEcCtD
Chlorpropamide—Dizziness—Thiotepa—urinary bladder cancer	0.000656	0.00438	CcSEcCtD
Chlorpropamide—Urticaria—Fluorouracil—urinary bladder cancer	0.000652	0.00435	CcSEcCtD
Chlorpropamide—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000644	0.0043	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000641	0.00428	CcSEcCtD
Chlorpropamide—Vomiting—Thiotepa—urinary bladder cancer	0.000631	0.00421	CcSEcCtD
Chlorpropamide—Rash—Thiotepa—urinary bladder cancer	0.000626	0.00418	CcSEcCtD
Chlorpropamide—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000625	0.00417	CcSEcCtD
Chlorpropamide—Headache—Thiotepa—urinary bladder cancer	0.000622	0.00415	CcSEcCtD
Chlorpropamide—Decreased appetite—Etoposide—urinary bladder cancer	0.00062	0.00413	CcSEcCtD
Chlorpropamide—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000617	0.00412	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000615	0.00411	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000593	0.00396	CcSEcCtD
Chlorpropamide—Pruritus—Gemcitabine—urinary bladder cancer	0.000591	0.00394	CcSEcCtD
Chlorpropamide—Nausea—Thiotepa—urinary bladder cancer	0.000589	0.00393	CcSEcCtD
Chlorpropamide—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000585	0.0039	CcSEcCtD
Chlorpropamide—Pruritus—Fluorouracil—urinary bladder cancer	0.000581	0.00387	CcSEcCtD
Chlorpropamide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000571	0.00381	CcSEcCtD
Chlorpropamide—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000568	0.00379	CcSEcCtD
Chlorpropamide—Urticaria—Etoposide—urinary bladder cancer	0.000566	0.00378	CcSEcCtD
Chlorpropamide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000562	0.00375	CcSEcCtD
Chlorpropamide—Dizziness—Fluorouracil—urinary bladder cancer	0.000543	0.00362	CcSEcCtD
Chlorpropamide—ABCB1—lymph node—urinary bladder cancer	0.000542	0.0039	CbGeAlD
Chlorpropamide—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000541	0.00361	CcSEcCtD
Chlorpropamide—Diarrhoea—Cisplatin—urinary bladder cancer	0.000532	0.00355	CcSEcCtD
Chlorpropamide—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000532	0.00355	CcSEcCtD
Chlorpropamide—Vomiting—Gemcitabine—urinary bladder cancer	0.000531	0.00354	CcSEcCtD
Chlorpropamide—Rash—Gemcitabine—urinary bladder cancer	0.000526	0.00351	CcSEcCtD
Chlorpropamide—Headache—Gemcitabine—urinary bladder cancer	0.000523	0.00349	CcSEcCtD
Chlorpropamide—Vomiting—Fluorouracil—urinary bladder cancer	0.000522	0.00348	CcSEcCtD
Chlorpropamide—Rash—Fluorouracil—urinary bladder cancer	0.000518	0.00345	CcSEcCtD
Chlorpropamide—Headache—Fluorouracil—urinary bladder cancer	0.000514	0.00343	CcSEcCtD
Chlorpropamide—Pruritus—Etoposide—urinary bladder cancer	0.000504	0.00337	CcSEcCtD
Chlorpropamide—Nausea—Gemcitabine—urinary bladder cancer	0.000496	0.00331	CcSEcCtD
Chlorpropamide—Vomiting—Cisplatin—urinary bladder cancer	0.000495	0.0033	CcSEcCtD
Chlorpropamide—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000492	0.00328	CcSEcCtD
Chlorpropamide—Rash—Cisplatin—urinary bladder cancer	0.000491	0.00327	CcSEcCtD
Chlorpropamide—Diarrhoea—Etoposide—urinary bladder cancer	0.000488	0.00325	CcSEcCtD
Chlorpropamide—Nausea—Fluorouracil—urinary bladder cancer	0.000488	0.00325	CcSEcCtD
Chlorpropamide—Dizziness—Etoposide—urinary bladder cancer	0.000471	0.00315	CcSEcCtD
Chlorpropamide—Leukopenia—Methotrexate—urinary bladder cancer	0.000468	0.00312	CcSEcCtD
Chlorpropamide—Nausea—Cisplatin—urinary bladder cancer	0.000462	0.00308	CcSEcCtD
Chlorpropamide—Vomiting—Etoposide—urinary bladder cancer	0.000453	0.00302	CcSEcCtD
Chlorpropamide—Rash—Etoposide—urinary bladder cancer	0.000449	0.003	CcSEcCtD
Chlorpropamide—Headache—Etoposide—urinary bladder cancer	0.000447	0.00298	CcSEcCtD
Chlorpropamide—Leukopenia—Epirubicin—urinary bladder cancer	0.000438	0.00292	CcSEcCtD
Chlorpropamide—Nausea—Etoposide—urinary bladder cancer	0.000423	0.00283	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000418	0.00279	CcSEcCtD
Chlorpropamide—Anorexia—Methotrexate—urinary bladder cancer	0.000407	0.00272	CcSEcCtD
Chlorpropamide—Leukopenia—Doxorubicin—urinary bladder cancer	0.000406	0.00271	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000391	0.00261	CcSEcCtD
Chlorpropamide—Anorexia—Epirubicin—urinary bladder cancer	0.000381	0.00254	CcSEcCtD
Chlorpropamide—Dyspepsia—Methotrexate—urinary bladder cancer	0.000376	0.00251	CcSEcCtD
Chlorpropamide—Decreased appetite—Methotrexate—urinary bladder cancer	0.000371	0.00248	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000369	0.00246	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000362	0.00242	CcSEcCtD
Chlorpropamide—Anorexia—Doxorubicin—urinary bladder cancer	0.000352	0.00235	CcSEcCtD
Chlorpropamide—Dyspepsia—Epirubicin—urinary bladder cancer	0.000352	0.00235	CcSEcCtD
Chlorpropamide—Decreased appetite—Epirubicin—urinary bladder cancer	0.000347	0.00232	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000345	0.0023	CcSEcCtD
Chlorpropamide—Urticaria—Methotrexate—urinary bladder cancer	0.000339	0.00226	CcSEcCtD
Chlorpropamide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000325	0.00217	CcSEcCtD
Chlorpropamide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000321	0.00214	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000319	0.00213	CcSEcCtD
Chlorpropamide—Urticaria—Epirubicin—urinary bladder cancer	0.000317	0.00212	CcSEcCtD
Chlorpropamide—Pruritus—Methotrexate—urinary bladder cancer	0.000302	0.00202	CcSEcCtD
Chlorpropamide—Urticaria—Doxorubicin—urinary bladder cancer	0.000294	0.00196	CcSEcCtD
Chlorpropamide—Diarrhoea—Methotrexate—urinary bladder cancer	0.000292	0.00195	CcSEcCtD
Chlorpropamide—Pruritus—Epirubicin—urinary bladder cancer	0.000283	0.00189	CcSEcCtD
Chlorpropamide—Dizziness—Methotrexate—urinary bladder cancer	0.000282	0.00188	CcSEcCtD
Chlorpropamide—Diarrhoea—Epirubicin—urinary bladder cancer	0.000273	0.00182	CcSEcCtD
Chlorpropamide—Vomiting—Methotrexate—urinary bladder cancer	0.000271	0.00181	CcSEcCtD
Chlorpropamide—Rash—Methotrexate—urinary bladder cancer	0.000269	0.0018	CcSEcCtD
Chlorpropamide—Headache—Methotrexate—urinary bladder cancer	0.000267	0.00178	CcSEcCtD
Chlorpropamide—Dizziness—Epirubicin—urinary bladder cancer	0.000264	0.00176	CcSEcCtD
Chlorpropamide—Pruritus—Doxorubicin—urinary bladder cancer	0.000262	0.00175	CcSEcCtD
Chlorpropamide—Vomiting—Epirubicin—urinary bladder cancer	0.000254	0.0017	CcSEcCtD
Chlorpropamide—Nausea—Methotrexate—urinary bladder cancer	0.000254	0.00169	CcSEcCtD
Chlorpropamide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000253	0.00169	CcSEcCtD
Chlorpropamide—Rash—Epirubicin—urinary bladder cancer	0.000252	0.00168	CcSEcCtD
Chlorpropamide—Headache—Epirubicin—urinary bladder cancer	0.00025	0.00167	CcSEcCtD
Chlorpropamide—Dizziness—Doxorubicin—urinary bladder cancer	0.000244	0.00163	CcSEcCtD
Chlorpropamide—Nausea—Epirubicin—urinary bladder cancer	0.000237	0.00158	CcSEcCtD
Chlorpropamide—Vomiting—Doxorubicin—urinary bladder cancer	0.000235	0.00157	CcSEcCtD
Chlorpropamide—Rash—Doxorubicin—urinary bladder cancer	0.000233	0.00156	CcSEcCtD
Chlorpropamide—Headache—Doxorubicin—urinary bladder cancer	0.000232	0.00155	CcSEcCtD
Chlorpropamide—Nausea—Doxorubicin—urinary bladder cancer	0.00022	0.00147	CcSEcCtD
Chlorpropamide—KCNJ11—Metabolism—NAT1—urinary bladder cancer	0.000178	0.00298	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—GSTO2—urinary bladder cancer	0.000178	0.00298	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000176	0.00294	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00017	0.00285	CbGpPWpGaD
Chlorpropamide—CYP2C19—Biological oxidations—NAT2—urinary bladder cancer	0.00017	0.00285	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000168	0.00281	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—UGT2B7—urinary bladder cancer	0.000168	0.00281	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—UGT2B7—urinary bladder cancer	0.000163	0.00272	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.00016	0.00268	CbGpPWpGaD
Chlorpropamide—PTGS1—Biological oxidations—GSTP1—urinary bladder cancer	0.000159	0.00265	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000156	0.00261	CbGpPWpGaD
Chlorpropamide—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.000155	0.0026	CbGpPWpGaD
Chlorpropamide—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.000155	0.0026	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000153	0.00256	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—CYP4B1—urinary bladder cancer	0.000151	0.00253	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—CYP4B1—urinary bladder cancer	0.000146	0.00245	CbGpPWpGaD
Chlorpropamide—PTGS1—Biological oxidations—GSTM1—urinary bladder cancer	0.000146	0.00244	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000143	0.0024	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—SLC19A1—urinary bladder cancer	0.000143	0.00239	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.00014	0.00235	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00014	0.00235	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—PRSS3—urinary bladder cancer	0.000139	0.00233	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—SLC19A1—urinary bladder cancer	0.000138	0.00232	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	0.000137	0.00229	CbGpPWpGaD
Chlorpropamide—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	0.000136	0.00228	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—PRSS3—urinary bladder cancer	0.000135	0.00226	CbGpPWpGaD
Chlorpropamide—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	0.000132	0.00221	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00013	0.00218	CbGpPWpGaD
Chlorpropamide—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000127	0.00213	CbGpPWpGaD
Chlorpropamide—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.000124	0.00208	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000122	0.00204	CbGpPWpGaD
Chlorpropamide—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000121	0.00203	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000121	0.00203	CbGpPWpGaD
Chlorpropamide—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.00012	0.00201	CbGpPWpGaD
Chlorpropamide—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000116	0.00194	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—TYMP—urinary bladder cancer	0.000111	0.00186	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000111	0.00185	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—TYMP—urinary bladder cancer	0.000108	0.0018	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—NAT2—urinary bladder cancer	0.0001	0.00168	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	9.81e-05	0.00164	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	9.76e-05	0.00164	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—NAT2—urinary bladder cancer	9.74e-05	0.00163	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	9.71e-05	0.00163	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.67e-05	0.00162	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	9.48e-05	0.00159	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—GSTO2—urinary bladder cancer	9.21e-05	0.00154	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—NAT1—urinary bladder cancer	9.21e-05	0.00154	CbGpPWpGaD
Chlorpropamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	9.15e-05	0.00153	CbGpPWpGaD
Chlorpropamide—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	9.14e-05	0.00153	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.05e-05	0.00152	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	9.01e-05	0.00151	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	8.95e-05	0.0015	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—RRM2—urinary bladder cancer	8.67e-05	0.00145	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	8.42e-05	0.00141	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—RRM2—urinary bladder cancer	8.41e-05	0.00141	CbGpPWpGaD
Chlorpropamide—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	8.4e-05	0.00141	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	8.35e-05	0.0014	CbGpPWpGaD
Chlorpropamide—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	8.33e-05	0.0014	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.28e-05	0.00139	CbGpPWpGaD
Chlorpropamide—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	8.27e-05	0.00139	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.22e-05	0.00138	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—HPGDS—urinary bladder cancer	8.03e-05	0.00135	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—ENO2—urinary bladder cancer	8.03e-05	0.00135	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	8e-05	0.00134	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	7.98e-05	0.00134	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—GSTT1—urinary bladder cancer	7.79e-05	0.0013	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—ENO2—urinary bladder cancer	7.79e-05	0.0013	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—HPGDS—urinary bladder cancer	7.79e-05	0.0013	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	7.76e-05	0.0013	CbGpPWpGaD
Chlorpropamide—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	7.66e-05	0.00128	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	7.63e-05	0.00128	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	7.58e-05	0.00127	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—GSTT1—urinary bladder cancer	7.55e-05	0.00127	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.55e-05	0.00126	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.29e-05	0.00122	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	7.16e-05	0.0012	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—PRSS3—urinary bladder cancer	6.98e-05	0.00117	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	6.76e-05	0.00113	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.57e-05	0.0011	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	6.52e-05	0.00109	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—NQO1—urinary bladder cancer	6.47e-05	0.00108	CbGpPWpGaD
Chlorpropamide—ABCC8—Neuronal System—HRAS—urinary bladder cancer	6.32e-05	0.00106	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—NQO1—urinary bladder cancer	6.28e-05	0.00105	CbGpPWpGaD
Chlorpropamide—KCNJ11—Neuronal System—HRAS—urinary bladder cancer	6.13e-05	0.00103	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.09e-05	0.00102	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	5.97e-05	0.001	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	5.95e-05	0.000996	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	5.92e-05	0.000992	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	5.81e-05	0.000974	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	5.6e-05	0.000938	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.59e-05	0.000937	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—TYMP—urinary bladder cancer	5.58e-05	0.000934	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	5.46e-05	0.000915	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—GSTP1—urinary bladder cancer	5.4e-05	0.000904	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.36e-05	0.000897	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	5.31e-05	0.000889	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—NAT1—urinary bladder cancer	5.31e-05	0.000889	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—GSTP1—urinary bladder cancer	5.24e-05	0.000877	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.22e-05	0.000874	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.19e-05	0.000869	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—GSTO2—urinary bladder cancer	5.18e-05	0.000868	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—NAT1—urinary bladder cancer	5.18e-05	0.000868	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	5.12e-05	0.000858	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	5.1e-05	0.000855	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—NAT2—urinary bladder cancer	5.04e-05	0.000845	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—TYMS—urinary bladder cancer	5.02e-05	0.000841	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—NCOR1—urinary bladder cancer	4.96e-05	0.000831	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—GSTM1—urinary bladder cancer	4.96e-05	0.000831	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—TYMS—urinary bladder cancer	4.87e-05	0.000815	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	4.85e-05	0.000813	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	4.84e-05	0.000811	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—NAT1—urinary bladder cancer	4.84e-05	0.000811	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—NCOR1—urinary bladder cancer	4.81e-05	0.000806	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—GSTM1—urinary bladder cancer	4.81e-05	0.000806	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.76e-05	0.000797	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—GPX1—urinary bladder cancer	4.75e-05	0.000796	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	4.74e-05	0.000794	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—ERCC2—urinary bladder cancer	4.67e-05	0.000781	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—GPX1—urinary bladder cancer	4.61e-05	0.000772	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.52e-05	0.000758	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—ERCC2—urinary bladder cancer	4.52e-05	0.000758	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	4.43e-05	0.000741	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.4e-05	0.000737	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—MTHFR—urinary bladder cancer	4.39e-05	0.000735	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	4.37e-05	0.000732	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—RRM2—urinary bladder cancer	4.35e-05	0.000729	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.35e-05	0.000728	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	4.27e-05	0.000715	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—MTHFR—urinary bladder cancer	4.25e-05	0.000712	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	4.25e-05	0.000712	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	4.13e-05	0.000691	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—HPGDS—urinary bladder cancer	4.03e-05	0.000675	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—ENO2—urinary bladder cancer	4.03e-05	0.000675	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	4.03e-05	0.000675	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	4.02e-05	0.000674	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.01e-05	0.000671	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	3.99e-05	0.000667	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—PRSS3—urinary bladder cancer	3.93e-05	0.000658	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—GSTT1—urinary bladder cancer	3.91e-05	0.000655	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.85e-05	0.000645	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.84e-05	0.000643	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	3.76e-05	0.00063	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.71e-05	0.000622	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.71e-05	0.000621	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	3.67e-05	0.000614	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—PPARG—urinary bladder cancer	3.56e-05	0.000596	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.53e-05	0.000592	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—PPARG—urinary bladder cancer	3.45e-05	0.000578	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.44e-05	0.000576	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—CREBBP—urinary bladder cancer	3.42e-05	0.000572	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—CREBBP—urinary bladder cancer	3.31e-05	0.000555	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—NQO1—urinary bladder cancer	3.25e-05	0.000544	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.22e-05	0.00054	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—TYMP—urinary bladder cancer	3.22e-05	0.000539	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.15e-05	0.000528	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—TYMP—urinary bladder cancer	3.14e-05	0.000526	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.09e-05	0.000517	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.08e-05	0.000516	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.01e-05	0.000505	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.94e-05	0.000493	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—TYMP—urinary bladder cancer	2.93e-05	0.000491	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—NAT2—urinary bladder cancer	2.91e-05	0.000487	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.87e-05	0.000481	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.85e-05	0.000477	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.84e-05	0.000475	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.82e-05	0.000472	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—PTGS2—urinary bladder cancer	2.8e-05	0.000469	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.75e-05	0.000461	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—PTGS2—urinary bladder cancer	2.71e-05	0.000454	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—GSTP1—urinary bladder cancer	2.71e-05	0.000454	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.65e-05	0.000444	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.62e-05	0.000439	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.53e-05	0.000424	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—TYMS—urinary bladder cancer	2.52e-05	0.000422	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.51e-05	0.00042	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—NCOR1—urinary bladder cancer	2.49e-05	0.000417	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—GSTM1—urinary bladder cancer	2.49e-05	0.000417	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.45e-05	0.00041	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—PTEN—urinary bladder cancer	2.44e-05	0.000409	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—GPX1—urinary bladder cancer	2.39e-05	0.0004	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—PTEN—urinary bladder cancer	2.37e-05	0.000396	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—ERCC2—urinary bladder cancer	2.34e-05	0.000392	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—EP300—urinary bladder cancer	2.33e-05	0.00039	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.32e-05	0.000389	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.32e-05	0.000389	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.31e-05	0.000387	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.29e-05	0.000383	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.27e-05	0.00038	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.27e-05	0.00038	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—EP300—urinary bladder cancer	2.26e-05	0.000378	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.25e-05	0.000378	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.22e-05	0.000372	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—MTHFR—urinary bladder cancer	2.2e-05	0.000369	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.2e-05	0.000369	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.12e-05	0.000355	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.12e-05	0.000355	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.11e-05	0.000353	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.06e-05	0.000345	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.06e-05	0.000344	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.02e-05	0.000339	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.87e-05	0.000314	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.83e-05	0.000306	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.82e-05	0.000305	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.79e-05	0.000299	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.71e-05	0.000287	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.71e-05	0.000286	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.66e-05	0.000278	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.59e-05	0.000266	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.56e-05	0.000262	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.53e-05	0.000256	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.51e-05	0.000253	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.45e-05	0.000243	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.45e-05	0.000242	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.44e-05	0.000241	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.44e-05	0.000241	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.43e-05	0.000239	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.42e-05	0.000238	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.4e-05	0.000235	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.4e-05	0.000235	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.4e-05	0.000235	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.38e-05	0.000231	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.38e-05	0.00023	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.35e-05	0.000226	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.34e-05	0.000225	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.32e-05	0.000222	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.32e-05	0.000221	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.31e-05	0.000219	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.31e-05	0.000219	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.27e-05	0.000213	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.25e-05	0.00021	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.24e-05	0.000208	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.23e-05	0.000206	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.22e-05	0.000205	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—EP300—urinary bladder cancer	1.17e-05	0.000196	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.16e-05	0.000194	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.03e-05	0.000172	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—PPARG—urinary bladder cancer	1e-05	0.000168	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	9.89e-06	0.000166	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—CREBBP—urinary bladder cancer	9.65e-06	0.000162	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—PPARG—urinary bladder cancer	9.38e-06	0.000157	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	9.02e-06	0.000151	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	8.1e-06	0.000136	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—PTGS2—urinary bladder cancer	7.9e-06	0.000132	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	7.38e-06	0.000124	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—PTEN—urinary bladder cancer	7.06e-06	0.000118	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—PTEN—urinary bladder cancer	6.89e-06	0.000115	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—EP300—urinary bladder cancer	6.73e-06	0.000113	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—EP300—urinary bladder cancer	6.57e-06	0.00011	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—PTEN—urinary bladder cancer	6.44e-06	0.000108	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—EP300—urinary bladder cancer	6.14e-06	0.000103	CbGpPWpGaD
